Novel approaches for drug delivery systems in nanomedicine: effects of particle design and shape
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The identification of novel drug candidates for the treatment of diseases like cancer, infectious diseases, or allergies (especially asthma) assigns new tasks for pharmaceutical technology. With respect to drug delivery several problems occur such as low solubility and hence low bioavailability or restriction to inconvenient routes of administration. Nanotechnological approaches promise to circumvent some of these problems, therefore being well suited for future applications as nanomedicines. Furthermore, efficient and sufficient loading is a critical issue that is approached through mesoporous particles and/or through nonspherical particles both offering larger volumes and surfaces. Special interest is laid on the effect of shape of particulate materials on the body and related physiological mechanisms. The modified response of biological systems on different shapes opens a new dimension to adjust particle system interaction. Finally, the biological response to these systems will determine the fate with respect to their therapeutic value. Therefore, the interaction pattern between nonspherical particulate materials and biological systems as well as the production processes are highlighted.WIREs Nanomed Nanobiotechnol 2012, 4:52–65. doi: 10.1002/wnan.165 This article is categorized under:Therapeutic Approaches and Drug Discovery > Emerging Technologies Nanotechnology Approaches to Biology > Nanoscale Systems in Biology
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
Donaldson, K., Aitken, R., Tran, L., Stone, V., Duffin, R., Forrest, G., & Alexander, A. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj130 · Cited by 1,167
Xia, T., Kovochich, M., Liong, M., Meng, H., Kabehie, S., George, S., Zink, J. I., & Nel, A. E. (2009) · ACS Nano · doi:10.1021/nn900918w · Cited by 933
Tuning Size and Sensing Properties in Colloidal Gold Nanostars
Barbosa, S., Agrawal, A., Rodríguez-Lorenzo, L., Pastoriza-Santos, I., Alvarez-Puebla, R. A., Kornowski, A., Weller, H., & Liz-Marzán, L. M. (2010) · Langmuir · doi:10.1021/la102559e · Cited by 522
Cited by
The importance of nanoparticle shape in cancer drug delivery
Truong, N. P., Whittaker, M. R., Mak, C. W., & Davis, T. P. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.950564 · Cited by 594
“It has been proposed that tumor-targeting accumulation of worm-like micelles can be directly attributed to shape [40,41].”
BackgroundInhibition of the Multidrug Resistance P-Glycoprotein: Time for a Change of Strategy?
Callaghan, R., Luk, F., & Bebawy, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056176 · Cited by 453
“Nanoparticles improve the therapeutic index (LD50/ED50) by increasing bioavailability (fraction of dose reaching circulation) and reducing toxicity (Daum et al., 2012).”
BackgroundRuge, C. A., Kirch, J., & Lehr, C.-M. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70072-9 · Cited by 280
Composite CD-MOF nanocrystals-containing microspheres for sustained drug delivery
Li, H., Lv, N., Li, X., Liu, B., Feng, J., Ren, X., Guo, T., Chen, D., Fraser Stoddart, J., Gref, R., et al. (2017) · Nanoscale · doi:10.1039/c6nr07593b · Cited by 276
Nafee, N., Husari, A., Maurer, C. K., Lu, C., de Rossi, C., Steinbach, A., Hartmann, R. W., Lehr, C.-M., & Schneider, M. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.055 · Cited by 208
“The use of biocompatible, biodegradable nanoparticles for controlled drug/gene delivery at mucosal sites proved to be an effective therapeutic strategy [17].”
BackgroundSelf-citation
Metadata
- Authors
- Daum, N., Tscheka, C., Neumeyer, A., & Schneider, M.
- Venue
- WIREs Nanomedicine and Nanobiotechnology
- Publisher
- Wiley
- Published
- 2011-12-02
- Volume
- 4
- Issue
- 1
- Pages
- 52-65
- ISSN
- 1939-0041 (ISSN-L)
- 1939-5116
- OpenAlex
- W2167122804
- Cited by
- 117
- References
- 4
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.